2m 2m 2m 2m 2m 2m 2m
ERASCA (ERAS)
NASDAQ
$14.39-$0.11 (-0.72%)
Price as of Oct 22, 2026 4:27 PM EDT- $5.1BMarket Cap
- 538.33%1-Year Change
- BiotechnologyIndustry
ERASCA (ERAS)
$14.39-$0.11 (-0.72%)
ERAS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.49 | ||
Change | -$0.13 (-0.89%) | ||
Open | $14.82 | ||
High | $15.05 | ||
Low | $14.38 | ||
Previous Close | $14.62 | ||
Volume | 3,845,038 | ||
30-Day Average Volume | 5,193,212 | ||
1-Week Change | -1.43% | ||
1-Month Change | -3.66% | ||
1-Year Change | 538.33% | ||
3-Year Change | 552.70% | ||
5-Year Change | -25.08% | ||
Fundamentals | |||
Shares Outstanding | 349.8M | ||
Total Assets | $435.1M | ||
Market Cap | $5.1B | ||
Enterprise Value | $5.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$44.1M | ||
Free Cash Flow | -$27.3M | ||
EBIT | -$44.1M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $244.9M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -116 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 14 | ||
P/E | -104 | ||
PEG | -1 | ||
Price/Free Cash Flow | -186 | ||
Price/Operating Cash Flow | -186 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue